京新药业：向香港联交所递交H股发行上市申请

Group 1 - The company, Jingxin Pharmaceutical, announced that it submitted an application for the issuance of overseas listed shares (H shares) and for listing on the main board of the Hong Kong Stock Exchange on February 11, 2026 [1] - The application materials for this issuance and listing were published on the Hong Kong Stock Exchange website on the same day [1]